National and Kapodistrian University of Athens
Μελέτη της ρύθμισης της έκφρασης γονιδίων σηματοδοτικών μονοπατιών από μη κωδικά μόρια RNA (ncRNA), σε καρκινικά κύτταρα μαστού
Abstract
dc:descriptionBreast cancer is characterized by high mortality and dysregulation of critical signaling pathways. Non-coding RNAs (ncRNAs), including large and small non-coding RNAs (sncRNAs), participate in post-transcriptional regulation through mechanisms such as RNA silencing, where miRNAs lead to mRNA degradation or suppression of mRNA translation via the RISC complex. Other sncRNAs exhibit similar regulatory activity, with relatively few molecules having been studied regarding their effect on breast cancer and cellular signaling. In this thesis, cell lines of different breast cancer molecular subtypes were used and treated with proteasome inhibitors to modulate signaling pathways. This was done to investigate specific and universal regulatory mechanisms among the molecular subtypes. Furthermore, the proteasome inhibitors used are being tested in clinical trials primarily for the treatment of advanced breast cancer, while they induce apoptosis through various pathways such as JNK and NFκB. Initially, the effect of inhibitors on the expression of miRNAs with a literature-confirmed role in cancer was studied. This analysis revealed significant heterogeneity among different molecular subtypes and time points. Specifically, miRNAs such as miR-1-3p, miR-421-3p, and miR-765-3p showed decreased levels at various time points, with the analysis of predicted targets demonstrating their significant impact on signaling pathways. Although these miRNAs have some already known roles, the universality of the changes in their levels suggests a potential significant regulatory role in breast cancer cell signaling. Numerous other miRNAs were found to have significant differences in their levels between cell lines belonging to different molecular subtypes. A combined sequencing approach was then performed, integrating sncRNA and poly(A)-RNA sequencing data. Numerous sncRNAs with unique or universal differences in their levels were observed across the conditions studied, with numerous regulatory interactions predicted in each molecular subtype, including less-studied categories of sncRNAs, such as tRNA-derived RNA fragments and piRNAs. The miR-489-3p and miR-876-3p showed consistently reduced expression, and miR-1827 showed increased expression across all conditions studied, while other miRNAs appeared to vary more specifically by molecular subtype. For several piRNAs, including piR-36318 and piR-39245, a significant difference in their levels was observed after treatment with inhibitors in a cell line. Regarding tRNA-derived RNA fragments, numerous molecules, including 5’-tRF-TRN-GTT11, 3’-tRF-TRQ-CTG3, and 5’-tRF-TRV-CAC14, stood out for their potential contribution to cellular signaling. In the next step, the role of miR-22-5p and miR-22-3p was further investigated; these were found to be significantly upregulated, with predicted targets downregulated in a triple-negative breast cancer cell line. Overexpression of miR-22 led to increased levels of the two miRNAs and decreased levels of their predicted mRNA targets, with the targets of miR-22-5p, INSR, ITGB8, and PIK3R1, which are key effectors of the PI3K/AKT pathway, being confirmed via the luciferase assay. Furthermore, the overexpression of miR-22 in the MDA-MB-468 cell line led to a reduction in cell proliferation and migration, suggesting its involvement in critical signaling pathways, while the levels of the abovementioned miRNAs and mRNAs showed a similar change in metastatic triple-negative breast cancer cell lines. Furthermore, another level of post-transcriptional regulation was investigated, involving the reduction of miRNA bioavailability by circular RNAs (circRNAs), with a potential impact on cell signaling. Through a combination of third- and next-generation sequencing technologies, 106 circRNAs of the BAX gene were identified, 82 of which were novel. These molecules exhibited significant structural diversity, such as shorter exon ends, the retention of introns, and the identification of single-exon transcripts. Their expression appeared to vary among molecular subtypes, while circRNAs with nearly universal expression or specific expression in a non-cancerous breast cell line were also identified. Numerous circRNAs are predicted to bind to miRNAs, such as miR-152-5p, indirectly regulating gene expression. Through these interactions, critical signaling pathways are affected, including MAPK, PI3K/AKT, and NFκB, supporting the existence of competing endogenous RNA (ceRNA) networks that regulate apoptosis via BAX. Furthermore, the presence of binding sites for RNA-binding proteins (RNA-binding proteins, RBPs), as well as the existence of competing binding sites for RBPs and miRNAs, suggests that the identified circRNAs participate in complex RNA-protein networks, enhancing their regulatory complexity. This study, using a combination of in-vitro and in-silico experimental approaches, identifies key molecules belonging to different RNA categories that, through multilevel interactions, are predicted to influence gene expression in breast cancer and regulate key signaling pathways.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsaraki, Katerina
- Κατσαράκη, Κατερίνα
Subjects
dc:subject × 21- Γονιδιακή έκφραση
- Οδοί σηματοδότησης
- Εναλλακτική συρραφή
- Αλληλούχηση επόμενης γενιάς
- Αλληλούχηση με νανοπόρους
- Μικρά μη-κωδικά RNA
- miRNAs
- tRFs
- circRNAs
- Gene expression
- Signaling pathways
- Alternative splicing
- Next-generation sequencing
- Nanopore sequencing
- Small non-coding RNAs
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Biological Sciences
- Natural Sciences
- Biochemistry and Molecular Biology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61661